Log in to save to my catalogue

Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization...

Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_556bd673500c45ae8473e751960454e8

Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization of Product and Outcomes of Clinical Application

About this item

Full title

Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization of Product and Outcomes of Clinical Application

Publisher

Galenos Publishing

Journal title

Turkish journal of haematology, 2022-08, Vol.39 (3), p.206-210

Language

English

Formats

Publication information

Publisher

Galenos Publishing

More information

Scope and Contents

Contents

ObjectiveChimeric antigen receptor T (CAR-T) cell therapies have already made an impact on the treatment of B-cell malignancies. Although CAR-T cell therapies are promising, there are concerns about commercial products regarding their affordability and sustainability. In this preliminary study, the results of the first production and clinical data...

Alternative Titles

Full title

Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization of Product and Outcomes of Clinical Application

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_556bd673500c45ae8473e751960454e8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_556bd673500c45ae8473e751960454e8

Other Identifiers

ISSN

1300-7777

E-ISSN

1308-5263

DOI

10.4274/tjh.galenos.2022.2022.0193

How to access this item